糖尿病患者COVID-19重症风险增至三倍:1型与2型糖尿病前瞻性分析
该前瞻性队列研究在137个服务网点的区域医疗网络中识别COVID-19病例,纳入无糖尿病者6138例、1型糖尿病40例、2型糖尿病273例。相比无糖尿病者,1型糖尿病患者住院调整比值比为3.90(95%CI 1.75-8.69),疾病严重程度更高调整比值比为3.35(95%CI 1.53-7.33),与2型糖尿病风险相似。1型糖尿病中HbA1c、高血压、种族、近期糖尿病酮症酸中毒、保险状态和糖尿病技术使用较少与疾病严重程度显著相关。
要点
- 1型糖尿病COVID-19住院风险约为无糖尿病者的3.90倍
- 1型糖尿病疾病严重程度更高风险约为无糖尿病者的3.35倍
- 1型糖尿病中HbA1c、高血压、近期DKA等与疾病严重程度显著相关
核心结论
- 糖尿病状态,无论1型还是2型,均独立增加COVID-19的不良影响。
- 1型糖尿病中可改变因素(如HbA1c)与相对静态因素(如种族和保险)相比影响显著但幅度有限。
- 研究提示该人群持续需要减轻SARS-CoV-2感染风险的干预。
研究设计与样本
- 前瞻性队列研究,在137个服务网点的区域医疗网络中识别COVID-19病例。
- 通过电子健康记录查询、病历审查和患者联系识别影响疾病严重程度的临床因素。
- 纳入无糖尿病者6138例、1型糖尿病40例、2型糖尿病273例。
主要发现
- 1型糖尿病相比无糖尿病者住院调整比值比为3.90(95%CI 1.75-8.69)。
- 1型糖尿病相比无糖尿病者疾病严重程度更高调整比值比为3.35(95%CI 1.53-7.33)。
- 1型糖尿病风险与2型糖尿病相似。
- 1型糖尿病中HbA1c、高血压、种族、近期糖尿病酮症酸中毒、保险状态和糖尿病技术使用较少与疾病严重程度显著相关。
临床怎么用
- 对1型糖尿病患者应重视COVID-19感染预防和重症风险分层管理。
- 关注HbA1c、高血压、近期DKA和糖尿病技术使用等可干预因素。
- 认识种族和保险状态等静态因素对重症风险的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To quantify and contextualize the risk for coronavirus disease 2019 (COVID-19)-related hospitalization and illness severity in type 1 diabetes. RESEARCH DESIGN AND METHODS: We conducted a prospective cohort study to identify case subjects with COVID-19 across a regional health care network of 137 service locations. Using an electronic health record query, chart review, and patient contact, we identified clinical factors influencing illness severity. RESULTS: We identified COVID-19 in 6,138, 40, and 273 patients without diabetes and with type 1 and type 2 diabetes, respectively. Compared with not having diabetes, people with type 1 diabetes had adjusted odds ratios of 3.90 (95% CI 1.75-8.69) for hospitalization and 3.35 (95% CI 1.53-7.33) for greater illness severity, which was similar to risk in type 2 diabetes. Among patients with type 1 diabetes, glycosylated hemoglobin (HbA1c), hypertension, race, recent diabetic ketoacidosis, health insurance status, and less diabetes technology use were significantly associated with illness severity. CONCLUSIONS: Diabetes status, both type 1 and type 2, independently increases the adverse impacts of COVID-19. Potentially modifiable factors (e.g., HbA1c) had significant but modest impact compared with comparatively static factors (e.g., race and insurance) in type 1 diabetes, indicating an urgent and continued need to mitigate severe acute respiratory syndrome coronavirus 2 infection risk in this community.
引用
- Gregory JM, Slaughter JC, Duffus SH, et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care. 2020. PMID: 33268335. doi:10.2337/dc20-2260
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。